Literature DB >> 10645402

p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years.

J A Regezi1, N P Dekker, A McMillan, V Ramirez-Amador, A Meneses-Garcia, L M Ruiz-Godoy Rivera, E Chrysomali, I O Ng.   

Abstract

Relatively rare squamous cell carcinomas of the tongue in young patients may be associated with different etiologic factors and pathogenetic mechanisms than carcinomas from the same site in older patients. Alterations in cell cycle proteins likely contribute to the biologic behavior of these neoplasms. The purpose of this investigation was to evaluate cell cycle proteins (p53, p21, Rb, MDM2) in lateral tongue cancers from patients at the two ends of the age spectrum. All available archived lateral tongue carcinomas from patients < 35 years (n = 36, 23 males and 13 females) were sectioned, immunohistochemically stained, and evaluated. Protein expression was scored as percent positive nuclei. An equal number of sequentially accessioned lateral tongue specimens from patients > 75 years (23 males and 13 females) were stained and compared. Positive p53 staining was seen in 18/36 of the < 35-year group versus 24/36 of the > 75-year group (p = 0.149). Increased p21 staining (both percent of positive cells and intensity) was evident in 25/32 of the < 35-year group versus 24/32 of the > 75-year group (p = 1.0). Increased p21 expression was seen in both p53-positive and -negative cases in both age groups. Rb protein was increased in 16/29 of the < 35-year group versus 17/26 of the > 75-year group (p = 0.58). Fourteen cases (4/35 vs 10/36, p = 0.135) showed positive MDM2 staining; MDM2-positive cases were also p53 positive in 4/4 younger and 8/10 older patients. We conclude that p53, p21, Rb, and MDM2 are over-expressed in lateral tongue cancers, and that immunohistochemical profiles are heterogeneous. A p53-independent pathway of p21 induction is supported by the results; p53 suppression may be associated with MDM2 protein expression in a subset of cancers. Significant differences in the expression of p53, p21, Rb, and MDM2 proteins are not evident in lateral tongue carcinomas from patients < 35 years as compared to patients > 75 years.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10645402     DOI: 10.1016/s1368-8375(98)00126-2

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

Review 1.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

Review 2.  Early onset oral tongue cancer in the United States: A literature review.

Authors:  Benjamin R Campbell; James L Netterville; Robert J Sinard; Kyle Mannion; Sarah L Rohde; Alexander Langerman; Young J Kim; James S Lewis; Krystle A Lang Kuhs
Journal:  Oral Oncol       Date:  2018-10-14       Impact factor: 5.337

3.  MicroRNA-149 targets specificity protein 1 to suppress human tongue squamous cell carcinoma cell proliferation and motility.

Authors:  Jingxin Chen; Jimin Chen; Weizhong Li
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

4.  The role of genetic factor in etiopathogenesis of squamous cell carcinoma of the head and neck in young adults.

Authors:  Wojciech Gawecki; Magdalena Kostrzewska-Poczekaj; Marzena Gajecka; Piotr Milecki; Krzysztof Szyfter; Witold Szyfter
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-26       Impact factor: 2.503

5.  Combination of genetic variants in cyclin D1 and retinoblastoma genes predict clinical outcome in oral cancer patients.

Authors:  Abitha Murali; Bipin T Varghese; R Rejnish Kumar; S Kannan
Journal:  Tumour Biol       Date:  2015-10-12

6.  p53 in head and neck cancer: functional consequences and environmental implications of TP53 mutations.

Authors:  Jenni K Peltonen; Henni M Helppi; Paavo Pääkkö; Taina Turpeenniemi-Hujanen; Kirsi H Vähäkangas
Journal:  Head Neck Oncol       Date:  2010-12-15

7.  Distinctive pattern of let-7 family microRNAs in aggressive carcinoma of the oral tongue in young patients.

Authors:  Ohad Hilly; Nir Pillar; Sagit Stern; Yulia Strenov; Gideon Bachar; Noam Shomron; Thomas Shpitzer
Journal:  Oncol Lett       Date:  2016-07-20       Impact factor: 2.967

8.  MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor.

Authors:  Chao Hou; Yan Dong; Fenghe Zhang; Bo Du
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

9.  A comparative study of histological grade and expression of Ki67 protein in oral squamous cell carcinoma in young and old patients.

Authors:  Parviz Deyhimi; Nakisa Torabinia; Aitin Torabinia
Journal:  Dent Res J (Isfahan)       Date:  2013-07

10.  The expression of retinoblastoma tumor suppressor protein in oral cancers and precancers: A clinicopathological study.

Authors:  Sunila Thomas; Anita Balan; Prabha Balaram
Journal:  Dent Res J (Isfahan)       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.